tiprankstipranks
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market

Traws Pharma (TRAW) Stock Investors

Compare
1,831 Followers
Based on 794,476 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold TRAW
On average, investors allocate 0.00% of their portfolios to TRAW
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 794,476 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding TRAW

1.4%
Last 7
Days
1.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding TRAW, out of 794,476 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

TRAW Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.03%
$6.68
Based on the activity of investors who made their portfolios public
The table shows changes in TRAW in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

TRAW Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Nio
8.84%
-0.90%
-0.30%
7.66B
Consumer Cyclical
Lucid Group
5.41%
+0.24%
+1.52%
7.03B
Consumer Cyclical
Viking Therapeutics
3.82%
-1.48%
-2.87%
2.72B
Healthcare
Marathon Digital Holdings
4.95%
-1.11%
-0.68%
3.88B
Financial
Riot Platforms
4.58%
-1.40%
-1.74%
2.56B
Financial
Ford Motor
5.68%
-0.72%
+0.16%
37.94B
Consumer Cyclical
Block
3.63%
-0.89%
+4.10%
33.43B
Technology
Delta Air Lines
4.60%
+0.26%
+4.34%
25.01B
Industrials
GE Aerospace
4.43%
-1.03%
+0.66%
201.38B
Industrials
Boeing
4.99%
-1.62%
+1.64%
113.55B
Industrials
Based on the activity of 794,476 active portfolios
Open your Smart Portfolio

TRAW Investor Analysis

TRAW investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.5%
of TRAW holders
are under 35
Average Segment Performance
Average P/E Ratio17.86
Beta11.00
Dividend Yield3.91%
TRAW investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
60.9%
of TRAW holders
are between 35–55
Average Segment Performance
Average P/E Ratio16.98
Beta19.48
Dividend Yield3.42%
TRAW investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
28.6%
of TRAW holders
are over 55
Average Segment Performance
Average P/E Ratio13.92
Beta12.14
Dividend Yield3.66%
Overview of age group and performance of TRAW stock investors
See who invests in TRAW according to age group and performance.

FAQ

How many retail Investors hold TRAW?
<0.1% of TipRanks' retail investors hold TRAW in their portfolios.
    What is TRAW Investor Sentiment?
    TRAW’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of TRAW in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of TRAW in the last 7 days.
        What percentage of retail investors changed their holding of TRAW in the last 30 days?
        ▼ 1.5% of TipRanks' retail investors changed their holding of TRAW in the last 30 days.
          What is the average age of retail investors who hold TRAW?
          The average age of TRAW Holders is between 35–55.
            What other stocks have TRAW investors also bought?
            TRAW Investors also bought NIO, LCID, VKTX, MARA, RIOT, F, XYZ, DAL, GE, BA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              LCTXLineage Therap
              CNCCentene
              ELMDElectromed
              GSKGlaxoSmithKline
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis